8-KOther EventsExhibits & Filings

HCA Healthcare, Inc. 8-K Report, Corporate Update (Feb 5, 2016)

Filed February 5, 2016For Securities:HCA

Summary

HCA Healthcare, Inc. (HCA) filed an 8-K on February 5, 2016, to report on a significant legal development. The company announced that the Davidson County Circuit Court of Tennessee preliminarily approved a settlement in a consolidated shareholder derivative action, styled "Bagot v. Bracken, et al.". This settlement is subject to final court approval and aims to resolve claims brought by shareholders against the company's management and board. This preliminary approval is a crucial step towards resolving ongoing litigation that could have impacted the company's governance and financial standing. Investors should note that while this represents progress in settling the derivative action, the ultimate resolution and any associated financial implications will depend on the final court approval. The full details of the proposed settlement and the notice to shareholders regarding its pendency are made available through this filing and referenced on HCA's and the plaintiffs' attorneys' websites.

Key Highlights

  • 1HCA Holdings, Inc. (HCA) reported a preliminary court approval of a settlement in a consolidated shareholder derivative lawsuit.
  • 2The lawsuit, styled "Bagot v. Bracken, et al.", was filed in the Davidson County Circuit Court of Tennessee.
  • 3The preliminary approval was granted by the Court on January 28, 2016, via an Order Preliminarily Approving Settlement and Providing for Notice.
  • 4The proposed settlement is contingent upon final approval from the Court.
  • 5A Notice of Pendency of Proposed Settlement of Shareholder Derivative Action has been filed as an exhibit to this 8-K.
  • 6Further details regarding the settlement and the notice can be found on HCA's corporate website and the plaintiffs' attorneys' website.

Frequently Asked Questions

This 8-K filing is primarily to inform investors that HCA Healthcare has received preliminary court approval for a settlement in a shareholder derivative lawsuit. This is a significant legal development for the company.

A shareholder derivative lawsuit is a legal action brought by a shareholder on behalf of a corporation against a third party, typically corporate insiders like directors or officers, for alleged wrongdoing that harmed the corporation. In this case, the lawsuit was consolidated and styled "Bagot v. Bracken, et al."

No, this is only a preliminary approval. The settlement must still receive final approval from the Davidson County Circuit Court before it is officially resolved. The filing includes a notice for shareholders regarding the proposed settlement.

The filing states that the Notice of Pendency of Proposed Settlement and the complete Stipulation of Settlement are available on HCA's website and the shareholder derivative plaintiffs' attorneys' website. Information contained on these websites is not incorporated into the 8-K filing itself.